Search
Solventum Corp
SOLVAdd to Watchlist
86.220USD
+5.750+7.15%
Close 07-28 16:00（ET）Quotes delayed by 15 min
14.96BMarket Cap
10.48P/E TTM
Earnings Forecast
Currency: USD Updated: 2026-07-27The current earnings forecast score of Solventum Corp is 7.13, ranking 156 out of 199 in the Healthcare Equipment & Supplies industry. The average price target is 85.00, with a high of 103.00 and a low of 72.00.
Analyst Rating
Based on
16
analysts
Buy
Current Rating
83.493
Target Price
+7.03%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
109
Total
7
Median
9
Average
Company name
Ratings
Analysts
Solventum Corp
SOLV
16
Medtronic PLC
MDT
34
Dexcom Inc
DXCM
32
Stryker Corp
SYK
32
Zimmer Biomet Holdings Inc
ZBH
31
Abbott Laboratories
ABT
29
1
2
3
...
22
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FAQs
What is Solventum Corp's expected revenue for the next quarter?
Solventum Corp's expected revenue is 2.16B.
What is Solventum Corp's price target?
Analysts forecast that Solventum Corp's price target is USD 85.00, with the highest forecast at USD 103.00 and the lowest forecast at USD 72.00.
How have Solventum CorpSOLV's recent earnings per share performed?
The market expectation was USD 0.07, while Solventum CorpSOLV's earnings per share (EPS) for the previous quarter was USD 0.36. EPS for the next quarter is expected at USD 1.91.
What is the analyst rating for Solventum Corp?
Based on the ratings of Solventum Corp's stock from 16 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.